Posted by Michael Wonder on 20 May 2017
CO.DON: decisive step towards European expansion
18 May 2017 - Positive opinion from relevant committee for EU approval of articular cartilage product
In the course of the ongoing application for EU marketing authorisation, CO.DON AG received today the official positive opinion from the CHMP for its articular cartilage product. The recommended indication is the repair of symptomatic articular cartilage defects on the femoral condyle and the knee patella; defects of up to 10 cm² for adults.
The CHMP assessment forms the basis for a decision by the European Commission on EU-wide marketing authorisation for the product. In the past the European Commission has followed the recommendations of CHMP for the great majority of applications.
